期刊文献+

乳腺癌组织TGFβ_1及其受体与NF-κB表达的研究 被引量:2

EXPRESSION OF TGFβ_1, TGFβRI AND NFκB IN BREAST CANCER
下载PDF
导出
摘要 目的研究转化生长因子(TGF)β1及其I型受体(TGFβRI)与核转录因子(NF)κB在乳腺癌组织中的蛋白表达及其与临床病理特征的关系。方法建立40例乳腺癌标本共120个微组织的组织芯片,应用免疫组织化学SP法检测乳腺癌组织TGFβ1、TGFβRI与NFκB蛋白的表达情况。结果TGFβ1、TGFβRI和NFκB在乳腺癌中均有表达,三者过表达率分别为80%、65%和80%;TGFβ1的表达强度与TNM分期、组织学分级、腋淋巴结受累呈正相关(P<005,P<001和P<001),NFκB的表达强度与组织学分级、TNM分期呈正相关(P<005),TGFβRI的表达与分级、TNM分期、腋淋巴结受累均无明显相关性;TGFβ1和NFκB的表达呈显著正相关(P<001)。结论TGFβ1和NFκB的过表达与乳腺癌恶性及预后有密切关系,NFκB可能在一定程度上受到TGFβ1的调控。 ? Objective To investigate the protein expressions of TGFβ 1, TGFβRIand NF κBin breast cancer and their relations to the clinicopathological features. Methods The protein expression of TGFβ 1, TGFβRIand NFκB examinated in tissue chips from 40cases of breast carcinoma usingS P immunohistochemical method. Results All the cases expressed the protein of TGFβ 1, TGFβRIand NF κB, with an overexpression rates of 80%, 65% and 80%, respectively. The expression level of TGFβ 1 was positively correlated to TNM staging, histological grading and axillary lymph node metastasis( P <0 01, P <0 01 and P <0 05, respectively).The expression level of NF κBwas positively correlated to histological gradingand TNM staging( P <0 05). But the expression levelof TGFβRIshowed no correlation to histological grading, TNM staging or axillary lymph node metastasis. Conclusion The overexpression ofTGFβ 1 and NF κB might be closely correlated tothe malignancy degree and prognosis of breast cancer.The levels of NF κB might be regulated by TGFβ 1. 〔
出处 《中国组织化学与细胞化学杂志》 CAS CSCD 2004年第4期521-526,共6页 Chinese Journal of Histochemistry and Cytochemistry
关键词 乳腺癌 转化生长因子Β1 转化生长因子βⅠ型受体 核转录因子ΚB 免疫组织化学 Breast cancer Transforming growthfactorβ 1 Type I of transforming growthfactor beta receptor Nuclear factor-kappa B Immunohistochemistry
  • 相关文献

参考文献10

  • 1Tavassoli EF, Devilee WHO. Pathology and genetics, Tumours of the breast and femal genital organs. Lyon: IARC Press, 2003,10:10-12
  • 2Masi L, Malentacchi C, Campanacci D, et al. Transforming growth factor-β isoform and receptor expression in chondrosarcoma of bone. Virchows Arch, 2002,440(5): 491-497
  • 3Handel ML, McMorrow LB, Gravallese EM. Nuclear factor-kappa B in rheumatoid synovium. Localization of p50 and p65. Arthritis Rheum,1995,38(12):1762-1770
  • 4Muraoka RS, Dumont N, Ritter CA, et al. Blockade of TGF-β inhibits mammary tumor cell viability, migration and metastases. J Clin Invest, 2002, 109(12):1551-1559
  • 5Teicher BA. Malignant cells, directors of the malignant process: Role of transforming growth factor-beta. Cancer Metastasis Rev, 2001,20(2): 133-143
  • 6王晓冰,庞恩桥,黄照权,李春英,李华,黄柳明.转化生长因子β_1及其Ⅰ、Ⅱ型受体在乳腺癌中的表达及意义[J].肿瘤防治研究,2002,29(3):194-196. 被引量:4
  • 7Cardillo MR, Yap E, Castagna G. Molecular genetic analysis of TGFβ1 in breast cancer. J Exp Lin Res, 1997,16(1): 57-63
  • 8Evertsson S, Sun XF. Protein expression of NF-kappaB in human colorectal adenocarcinoma. Int J Mol Med, 2002, 10(5): 547-550
  • 9Oya M, Takayanagi A, Horiguchi A, et al. Increased nuclear factor-kappa B activation is related to the tumor development of renal cell carcinoma. Carcinogenesis, 2003, 24(3): 377-384
  • 10Zhu Y, Culmsee C, Klumpp S, et al. Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways. Neuroscience, 2004,123(4): 897-906

二级参考文献7

  • 1Warana JL,Attisano L,Wieser R.Mechanism of activation of theTGF-beta receptor[].Nature.1994
  • 2Eisma RJ,Spiro JD,Biberstein SE,et al.Decreased expression of transforming growth factor-βreceptors on head and neck squamous carcinoma cells[].The American Journal of Surgery.1996
  • 3Marrogi AJ,Munshi A,Merogi AJ,et al.Study of tumorinfiltrating lymphocytes and transforming growth factor-beta as prognostic factors in breast carcinoma[].International Journal of Cancer.1997
  • 4Murra PA,Burret LP,Travers M,et al.The prognosticsignificance of transforming growth factors in human breast cancer[].British Journal of Cancer.1993
  • 5Markowitz S,Wang J,Myeroff L,et al.Inactivation of the type II TGF-beta receptor in colon cancer cells with micro-satellite instability[].Science.1995
  • 6Cardillo MR,Yap E,Cstagna G.Molecular genetic analysis of TGFβ1 in breast cancer[].J Exp Lin Res.1997
  • 7Massague J.Receptor for the TGFβ1 family[].Cell.1992

共引文献3

同被引文献24

  • 1周正平,王进京,郑洪,苏俊,肖庆邦.乳腺浸润性导管癌中cyclinD_1、p57^(KIP2)的表达及意义[J].肿瘤防治研究,2005,32(8):476-478. 被引量:6
  • 2蔡春友,付金瑞,刘妍菊,姚智.乳腺癌NF-κBHER2 VEGF-C与VEGFR3表达及其意义[J].中国肿瘤临床,2005,32(23):1333-1337. 被引量:7
  • 3车轶群,王海,齐军,郭健,刘芝华.食管鳞癌组织中SPARC蛋白表达的临床意义[J].中国肿瘤临床,2006,33(2):61-63. 被引量:12
  • 4Pessler F,Pendergrast P S,Hernandez N.Purification and characterization of FBI-1,a cellular factor that binds to the human immunodeficiency virus type 1 inducer of short transcripts[J].Mol Cell Biol,1997,17(7):3786.
  • 5Morrison D J,Pendergrast P S,Stavropoulos P,et al.FBI,a factor that binds to the HIV-1 inducer of short transcripts(IST),is a poz domain protein[J].Nucleic Acid Research,1999,5(27):1251.
  • 6Lee D K,Suh D,Edenberg H J,et al.POZ domain transcription factor,FBI-1,represses transcription of ADH5/FDH by interacting with the zinc finger and interfering with DNA binding activity of Spl[J].J Biol Chem,2002,277(30):26761.
  • 7Sen R,Baltimore D.Inducibility of kappa immunoglobulin enhancer-binding protein NF-kappaB by aposttranslationa[J]mechanism.Cell,1986,47:921.
  • 8Hayden MS,Ghosh S.Signaling to NF-κB[J].Genes Dev,2004,18(18):2195.
  • 9Nakshatri H,Bhat-Nakshatri P,Martin DA,et al.Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth[J].Mol Cell Biol,1997,17(7):3629.
  • 10Schmitt CA,Fridman JS,Yang M,et al.Dissecting p53 tumors uppressor Functions in vivo[J].Cancer Cell,2002,1(3):335.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部